Cocrystal Pharma, Inc. (COCP) stock
COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.98−0.01 (-1.00%)
Close on Nov 13, 2026Market cap $18.88MP/E –Yield –
Cocrystal Pharma profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Cocrystal Pharma's profit margin for the twelve months ending Dec 31, 2020 was -479.0%. For fiscal 2020 it was -479.0%, against -733.8% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -479.0% | +254.8 |
| FY2019 | Dec 31, 2019 | -733.8% | −690.9 |
| FY2011 | Dec 31, 2011 | -42.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -3013.3% | −2382.5 |
| Q1 FY2026 | Mar 31, 2026 | -1021.8% | −590.1 |
| Q4 FY2020 | Dec 31, 2020 | -292.7% | +11609.0 |
| Q3 FY2020 | Sep 30, 2020 | -546.0% | −184.2 |
| Q2 FY2020 | Jun 30, 2020 | -630.9% | −375.0 |
| Q1 FY2020 | Mar 31, 2020 | -431.7% | −490.2 |
| Q4 FY2019 | Dec 31, 2019 | -11901.7% | – |
| Q3 FY2019 | Sep 30, 2019 | -361.8% | – |
| Q2 FY2019 | Jun 30, 2019 | -255.9% | – |
| Q1 FY2019 | Mar 31, 2019 | 58.5% | – |
See a number that looks wrong?